Abbott Laboratories has agreed to a $670 million settlement to resolve lawsuits claiming its specialized infant formulas caused a dangerous intestinal disease in preterm babies.

The plaintiff dropped his case against Meta without receiving any payment, shifting focus to ongoing state-level legal battles over platform safety.